COMMUNIQUÉS West-GlobeNewswire

Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018
23/10/2018
BRIDGEWATER, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release [...]
Vericel to Report Third-Quarter 2018 Financial Results on November 6, 2018
23/10/2018
CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
PSIQ Files Form S-1 as First Step to Becoming an SEC Reporting Company and Uplisting to OTCQB
23/10/2018
SUNRISE, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) [...]
Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018
23/10/2018
ROCHESTER, N.Y., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]
Terra Tech Corp. Completes Sale of Western Avenue, Nevada Retail Dispensary for $6.25 million
23/10/2018
IRVINE, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, has completed its previously announced [...]
Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study
23/10/2018
FREMONT, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that more than 150 evaluable subjects [...]
Portola Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018
23/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results for [...]
Bespoke Extracts Applauds 16-Yr Old Racing Rookie Sean Kelly for Big First Place Finish at Daytona Race of Champions
23/10/2018
SUNNY ISLES, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, is pleased to congratulate Hairy Kiwi/Bespoke CBD-sponsored [...]
Veritas Announces Investment Into Cannabis Growing Facility Under Health Canada License
23/10/2018
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce a $1.25 million investment to acquire [...]
Trinity Biotech Announces Results for Q3, 2018
23/10/2018
DUBLIN, Ireland, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]
Ceapro Inc. Receives the 2018 Award for Most Innovative Raw Material at Cosmetics 360 Salon in Paris
23/10/2018
New chemical complex, beta glucan-Co enzyme Q10, attracts special attention as a potentially strong antioxidant to be incorporated in a new formulation from Company’s proprietary cosmeceutical products, Juvente DC [...]
SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for Treatment of Rheumatoid Arthritis (RA)
23/10/2018
Successful proof-of-concept study demonstrates positive long-term 24-month safety and efficacy data Results to be Presented in Two Poster Presentations Today during the American College of Rheumatology (ACR) / [...]
Neuronetics to Report Third Quarter 2018 Financial Results and Host Conference Call
23/10/2018
MALVERN, Pa., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Daré Bioscience, Inc. to Present at the Dawson James Small Cap Growth Conference
23/10/2018
SAN DIEGO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the Dawson [...]
Fulgent Genetics to Announce Third Quarter 2018 Financial Results on Tuesday November 6, 2018
23/10/2018
TEMPLE CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2018 financial results after the [...]
Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics' Lead Drug Candidate VB-111 until October 2033
23/10/2018
TEL AVIV, Israel, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced the issuance by the European Patent Office (EPO) of Patent No. 2908865, a composition of matter patent which covers VB- [...]
Healthwise Announces Dr. Adam Husney as CEO
23/10/2018
The Healthwise board of directors today named Dr. Adam Husney to be the next Healthwise CEO effective immediately BOISE, Idaho, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, [...]
Milestone Scientific Signs U.S. Distribution Agreement for the CompuFlo® Epidural System with Medical Device Distributor Clinical Technology, Inc.
23/10/2018
New distribution agreement follows successful trials with top anesthesiologists LIVINGSTON, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS ), a developer of computerized drug delivery [...]
BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018
23/10/2018
RALEIGH, N.C., Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living with chronic [...]

Pages